TRIGYN NSE filing

Trigyn Technologies files Regulation 74(5) certificate for quarter ended September 30, 2025

The RealCase readLow impact Neutral

Trigyn Technologies filed a Regulation 74(5) certificate for the quarter ended September 30, 2025, confirming no Demat/Remat requests were processed.

Why it matters

This is a standard regulatory compliance filing required by SEBI, indicating normal business operations without any material impact on the company's stock or business outlook.

The market read

The announcement is a routine compliance filing confirming no Demat/Remat requests, which has no direct positive or negative implications for the company's financial performance or operations.

Trigyn Technologies Limited has submitted a Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025. The certificate, issued by KF IN Technologies Limited, the Company's Registrar, Share Transfer and Depository Services agents, confirms that no Demat/Remat requests were processed during the quarter ended September 2025.

Filing to action

What to do with a filing like this

Trigyn Technologies Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Trigyn Technologies Limited. Read the original for the full detail.

View original filing